12217886 · Active · incorporated 7 years, 1 month ago · Cambridge
Biotech Biotech & Life Sciences Drug Discovery Series B+
Develops next-generation antibody therapies for the treatment of amyloidosis, including ATTR cardiomyopathy.
Immutrin Ltd is a private limited company registered at Companies House under number 12217886, incorporated on 20 September 2019, with a registered office in Cambridge. Its current status on the register is active. Its filed nature of business is research and experimental development on biotechnology (SIC 72110). Sonde has indexed 72 filings for this company, including 5 funding rounds. Its most recent round closed in April 2026, raising £23.2m.
| Round | Closed | Raised | Price per share |
|---|---|---|---|
| Round 5 | Apr 2026 | £23.2m | £48.00 |
| Round 4 | Sep 2024 | £1.2m | £40.00 |
| Round 3 | Apr 2023 | £1.9m | £26.97 |
| Round 2 | Mar 2022 | £300k | £20.00 |
| Round 1 | Dec 2019 | £300k | £10.00 |
Showing the 12 most recent of 72 filings.
See the complete cap table with every shareholder, founder tags, dilution across 8 share allotments, round-by-round fundraising history, and the full filing timeline — parsed from official Companies House documents.
Create a free account Sign inFree accounts open 3 companies in full detail — no card required.